Item 8.01 Other Events.

Enservco Corporation (the "Company") is filing this report to update the
Company's executive compensation disclosure for fiscal 2022 and other related
disclosure which will be incorporated by reference in a Registration Statement
on Form S-1 being filed by the Company with the Securities and Exchange
Commission (the "SEC") on the date hereof, and in any other registration
statement subsequently filed by the Company under the Securities Act of 1933, as
amended.

EXECUTIVE COMPENSATION

Summary Compensation Table

The following table sets forth the cash and non-cash compensation for the fiscal
years ended December 31, 2022 and 2021 earned by or awarded to (i) the
individual who served as the Company's principal executive officer at any time
during fiscal 2022, and (ii) the Company's two most highly compensated executive
officers who received compensation in excess of $100,000 during fiscal 2022.
These individuals are referred to as our "named executive officers."

     Name and                                                                          Non-Equity
    Principal        Fiscal                             Stock         

Option Incentive Plan All Other


     Position         Year     Salary       Bonus     Awards(1)      Awards(1)        Compensation        Compensation(2)       Total
Richard A. Murphy     2022    $ 175,000   $       -   $        -   $           -   $                 -   $          18,004   $   193,004
CEO and President     2021    $ 160,577   $       -   $        -   $           -   $                 -   $          16,035   $   176,612

Marjorie A.
Hargrave(3)
Former President      2022    $  86,845   $       -   $  112,000   $           -   $                 -   $         170,842   $   369,687
and CFO               2021    $ 250,000   $       -   $  187,000   $           -   $                 -   $           9,643   $   446,303

Mark K.
Patterson(4)          2022    $ 127,884   $       -   $  923,550   $           -   $                 -   $           9,067   $ 1,060,501
CFO                   2021    $       -   $       -   $        -   $           -   $                 -   $               -   $         -



     (1) Stock awards reflect the grant date fair value of the stock awards and
         option awards determined in accordance with Financial Accounting
         Standards Board Accounting Standards Codification ("ASC") Topic 718,

rather than the amounts paid to or realized by the named individual. The


         assumptions and methodologies used in the calculations of these amounts
         are set forth in the notes to the condensed consolidated financial
         statements included in our Quarterly Report on Form 10-Q for the nine

months ended September 30, 2022. Under generally accepted accounting

principles, compensation expense with respect to stock awards granted to

our executive officers is generally recognized over the vesting periods

applicable to the awards. The SEC disclosure rules require that we

present stock award amounts in the applicable row of the table above

using the entire grant date fair value of the awards granted during the

corresponding year (regardless of the period over which the awards are

scheduled to vest).

(2) Represents health, life, dental and vision insurance premiums, as well as

cell phone allowance, for all three named executive officers. For

Marjorie Hargrave, this also includes cash separation payments of

approximately $168,000 paid in 2022 as stipulated in her Separation


         Agreement and Release described below.


  (3) Marjorie A. Hargrave departed the Company effective April 22, 2022.


  (4) Mark K. Patterson joined the Company effective April 22, 2022.




--------------------------------------------------------------------------------

Narrative Disclosure to Summary Compensation Table



The Compensation Committee reviews and approves the terms and structure of the
compensation of the Company's executive officers. The Compensation Committee
considers various factors when evaluating and determining the terms and
structure of the Company's executive officer compensation, including the
following:

1. The executive's leadership and operational performance and potential to

enhance long-term value to the Company's stockholders;

2. The Company's financial resources, results of operations, and financial

projections;

3. Performance compared to the financial, operational, and strategic goals


     established for the Company;


  4. The nature, scope, and level of the executive's responsibilities;


  5. Competitive market compensation paid by other companies for similar
     positions, experience, and performance levels; and

6. The executive's current salary, the appropriate balance between incentives

for long-term and short-term performance.

Management is responsible for reviewing the base salary, annual bonus and long-term compensation levels for other Company employees, and the Company expects this practice to continue going forward. The entire Board remains responsible for significant changes to, or adoption, of new employee benefit plans.

The Company believes that the compensation environment for qualified professionals in the industry in which we operate is competitive. In order to compete in this environment, the compensation of our executive officers is primarily comprised of the following four components:



  ? Base salary;


  ? Annual short-term incentive plan compensation (cash bonus awards);


  ? Long-term incentive compensation (equity awards); and


  ? Other employment benefits.


Base Salary



Base salary, paid in cash, is the first element of compensation to our officers.
In determining base salaries for our key executive officers, the Company aims to
set base salaries at a level we believe enables us to hire and retain
individuals in a competitive environment and to reward individual performance
and contribution to our overall business goals. The Board believes that base
salary should be relatively stable over time, providing the executive a
dependable, minimum level of compensation, which is approximately equivalent to
compensation that may be paid by competitors for persons of similar abilities.
The Board believes that base salaries for our executive officers are appropriate
for persons serving as executive officers of public companies that are similar
in size and complexity to the Company.

Mr. Murphy is the Company's Executive Chair and CEO and Mr. Patterson is the
Company's CFO. Neither of these executive officers have written employment
agreements with the Company, but they both have a base salary as well as
standard benefits. Mr. Murphy and Mr. Patterson both receive annual salaries of
$175,000 per year.

Cash Bonuses

Historically, discretionary cash bonuses were another element of our
compensation plan. These discretionary cash bonuses provided executive officers
and other employees with the potential to receive a portion of their annual cash
compensation as a cash bonus in order to encourage performance to achieve key
corporate objectives and to be competitive from a total remuneration standpoint.
We did not establish a set formula for determining or awarding discretionary
cash bonuses to our other executives or employees. In determining whether to
award bonuses and the amount of any bonuses, we have taken and expect to
continue to take into consideration discretionary factors such as the
individual's current and expected future performance, level of responsibilities,
retention considerations, and the total compensation package, as well as the
Company's overall performance including cash flow and other operational factors.

The Board did not award any discretionary bonuses to the named executive officers during 2022.

Equity-Based Compensation



Each of the Company's executive officers is eligible to be granted awards under
the Company's equity compensation plans. The Company believes that equity-based
compensation helps align management and executives' interests with the interests
of our stockholders. Our equity incentives are also intended to reward the
attainment of long-term corporate objectives by our executives. We also believe
that grants of equity-based compensation are necessary to enable us to be
competitive from a total remuneration standpoint. At the present time, we have
one active equity incentive plan for our management and employees, the 2016
Stock Incentive Plan (the "2016 Plan"), and one dormant equity incentive plan
for our management and employees, the 2010 Stock Incentive Plan (the "2010
Plan"), pursuant to which there are still outstanding awards.


--------------------------------------------------------------------------------


Historically, in determining whether to grant awards and the amount of any
awards, the Company took into consideration discretionary factors such as the
individual's current and expected future performance, level of responsibilities,
retention considerations, and the total compensation package. In 2018, the
Company adopted the Long-Term Incentive Plan ("LTIP"), which is intended to
balance the short-term orientation of other compensation elements, further align
management and shareholder interests, focus named executive officers on
achievement of long-term results, and retain executive talent. The Company's
named executive officers and senior managers have been eligible to receive
awards under the LTIP. All awards granted under the LTIP have been made pursuant
to the 2016 Plan.

The Company has granted equity-based compensation to named executive officers as described below and as reflected in the table entitled "Outstanding Equity Awards at Fiscal Year-End."



In January 2021, Ms. Hargrave was granted 100,000 shares of restricted stock.
25% of these shares of restricted stock vested on January 1, 2022, 25% vested
early on May 16, 2022 in accordance with the accelerated vesting stipulation in
Ms. Hargrave's Separation Agreement and Release discussed below. The remaining
50% were set to vest based upon achievement of certain performance metrics. As a
result of Ms. Hargrave's voluntary departure from the Company effective April
22, 2022, the remaining 50% of these performance based shares have been
forfeited and will not vest. However, pursuant to Mrs. Hargrave's Separation
Agreement and Release, 50,000 shares of additional Company common stock were
granted to Ms. Hargrave on April 22, 2022.

On April 15, 2022, Mark Patterson was granted a 300,000 share restricted stock
award that will be subject to transfer and forfeiture restrictions that will
lapse in three equal installments of 100,000 restricted shares on each of July
1, 2022, January 1, 2023, and January 1, 2024, subject to his continuous service
through each vesting date. Additionally, the Company granted Mr. Patterson a
45,000 share restricted stock award on April 22, 2022, which will be subject to
transfer and forfeiture restrictions that will lapse in three equal installments
of 15,000 restricted shares on each of July 1, 2022, January 1, 2023, and
January 1, 2024, subject to his continuous service through each vesting date.
Mr. Patterson's 45,000 share restricted stock award was issued pursuant to the
2016 Plan, whereas his 300,000 share restricted stock award was not.

Other Compensation/Benefits



Another element of the overall compensation is through providing our executive
officers various employment benefits, such as the payment of health and life
insurance premiums on behalf of the executive officers. Our executive officers
are also eligible to participate in our 401(k) plan on the same basis as other
employees and the Company historically has made matching contributions to the
401(k) plan, including for the benefit of our executive officers. In April 2020,
the Company ceased all matching to all employees including officers of its
401(k) plan.

Marjorie Hargrave Employment Agreement and Separation Agreement and Release



The Company entered into an employment agreement with Ms. Hargrave effective
July 24, 2019 (the "Hargrave Employment Agreement") in connection with the
appointment of Ms. Hargrave as Chief Financial Officer. The Hargrave Employment
Agreement provided for an initial term of one year and was set to renew for
additional one-year terms unless the Company provides Ms. Hargrave with a notice
of non-renewal at least 60 days prior to the then-current term. Pursuant to the
Hargrave Employment Agreement, Ms. Hargrave received an annual base salary of
$230,000 through December 31, 2020. Effective January 1, 2021, Ms. Hargrave's
annual base salary was increased to $250,000. In addition, Ms. Hargrave was
eligible each year to receive a discretionary bonus in addition to her base
salary, which would be awarded in such amounts as the Board determined, and was
eligible to receive long-term equity incentive awards. In connection with
entering into the Hargrave Employment Agreement, on July 24, 2019, Ms. Hargrave
was granted 22,000 restricted shares of common stock, half of which were
time-vested and half of which were performance-vested. The time-vested portion
of the restricted shares vested in one-third installments on each of January 23,
2020, January 23, 2021, and January 23, 2022, all of which have vested as of the
date of this filing. The performance-vested portion of the restricted shares
were subject to two performance metrics: (i) 6,600 restricted shares would vest
upon the Company achieving a 90-day moving average stock price of at least
$27.75 per common share, adjusted for stock splits, and (ii) 4,400 restricted
shares would vest upon the Company achieving a ratio of Trailing Twelve-Month
EBITDA to Consolidated Debt of 1.0 to 1.5, in each case subject to Ms.
Hargrave's continued employment with the Company.


--------------------------------------------------------------------------------


Under the Hargrave Employment Agreement, if the Company terminated Ms.
Hargrave's employment without cause, or Ms. Hargrave's employment was terminated
as a result of her disability or death, Ms. Hargrave would be entitled to
receive severance compensation in an amount equal to six months of her
then-current base salary, plus bonus severance equal to the greater of her most
recent discretionary bonus or three months of her then-current base salary, each
to be paid in a lump sum with five business days following termination. In
addition, Ms. Hargrave would be entitled to receive the same or similar health
care benefits as provided to her at the time of termination for six months from
the date of termination, all non-vested equity awards held by Ms. Hargrave would
immediately vest, and any stock options which were the subject of such awards
would be exercisable for a period of three months following such termination in
accordance with the applicable Company equity incentive plan under which such
options were granted.

Upon a change of control event, as defined in the Hargrave Employment Agreement,
all non-vested equity awards held by Ms. Hargrave would immediately vest and any
stock options which are the subject of such awards would be exercisable for the
longer of: (i) three months following the change of control event, or (ii) the
period set forth for the exercise of any such stock options held by any employee
in the agreement accomplishing the change of control event. If, within twelve
months following a change of control event, Ms. Hargrave's employment was
terminated by the Company or she resigned after receiving notice that the
Hargrave Employment Agreement would not be renewed, Ms. Hargrave would be
entitled to receive six months of her then-current base salary, plus 100% of the
target amount of any discretionary bonus that she would have been eligible to
earn in the year of termination, to be paid as a lump-sum within five days
following the date of termination. She would also be entitled to six months of
continued health care benefits.

On April 13, 2022, following notice of her intent to depart, the Company entered
into a Separation Agreement and Release with Ms. Hargrave.  Under the Separation
Agreement and Release, the Company and Ms. Hargrave mutually agreed that Ms.
Hargrave's employment would end on April 22, 2022. As a replacement for certain
compensation and benefits provided in the Hargrave Employment Agreement, and in
exchange for Ms. Hargrave's waiver and release of claims, the Company agreed to
provide Ms. Hargrave with the following separation benefits: (i) pay $187,000
(less applicable taxes) in monthly installments over a nine month period; b) pay
the cost of medical insurance coverage through January 31, 2023 or until Ms.
Hargrave becomes eligible through full-time employment with another employer to
obtain comparable replacement coverage, whichever occurs first; (iii) accelerate
the vesting of 25,000 time-vested restricted shares as of  May 16, 2022; and
(iv) receive 50,000 shares of Company common stock on April 22, 2022.

Outstanding Equity Awards at Fiscal Year-End

The following table sets forth the outstanding equity awards for each named executive officer at December 31, 2022.



                                                                                                   Equity
                                                                                               Incentive Plan
                                                                                  Equity       Awards: Market
                                                                              Incentive Plan         or
                                                                              Awards: Number    Payout Value
                                                                                    of               of
                                                                                 Unearned         Unearned
                                                                                 Shares,          Shares,
                                                                              Units or Other   Units or Other
                       Number of Shares or          Market Value of Shares        Rights           Rights
                       Units of Stock That          or Units of Stock That    That Have Not    That Have Not
        Name             Have Not Vested               Have Not Vested            Vested           Vested

Richard A. Murphy                        -       $                -                        -                -
Marjorie A. Hargrave                     -       $                -                        -                -
Mark K. Patterson                  230,000 (1)   $          374,900 (2)                    -                -


(1) Represents unvested shares related to the 300,000 share restricted stock

award issued effective April 15, 2022, that will vest in 100,000

restricted share installments on January 1, 2023 and January 1, 2024, and

the 45,000 share restricted stock award issued effective April 22, 2022,

that will vest in 15,000 restricted share installments on January 1, 2023

and January 1, 2024. The April 2022 grants were recorded by the transfer

agent on September 19, 2022.

(2) Market value calculations based on the Company's closing stock price of

$1.63 on December 30, 2022, the last trading day during the year ended
         December 31, 2022.




--------------------------------------------------------------------------------

Director Compensation



For Board service during 2022, each non-employee director earned a quarterly
director fee of $5,000. In addition, the Chair of each Board committee received
a $2,500 quarterly fee, and each director received a $1,000 attendance fee for
each special board meeting and committee meeting attended. In addition, on
January 1 of each year, the Company grants to each non-employee director a
number of shares of restricted stock of the Company having a value equal to
$30,000, calculated based on the closing price of the Company's common stock on
the business day prior to the grant date. The restricted stock will vest upon
the earliest of the one-year anniversary of the grant date, or the date of the
first annual meeting following the grant date, or the date on which a director
resigns following a change in control of the Company. As Chair of the Board, Mr.
Murphy did not earn any board fees due to his employment with the Company.

2022 Director Compensation Table

The table below reflects compensation paid to the non-employee members of the Board during the year ended December 31, 2022.



                                                                 All Other Compensation
    Director        Fees Paid in Cash     Stock Awards ($)(1)            Awards                Total
Robert S. Herlin   $            10,500   $              30,000   $                    -   $         40,500
William A. Jolly   $            10,500   $              30,000   $                    -   $         40,500


(1) Amounts represent the grant date fair value of the stock awards calculated

in accordance with ASC 718-10, Stock Compensation, rather than the amounts

paid to or realized by the named individual. For information regarding

assumptions used to calculate fair value under the Black-Scholes-Merton

valuation model, see the notes to the condensed consolidated financial

statements included in our Quarterly Report on Form 10-Q for the nine months

ended September 30, 2022.

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

Security Ownership of Certain Beneficial Owners and Management



The following table sets forth as of January 9, 2023 certain information
regarding beneficial ownership of the Company's common stock by: (i) each person
known to us to beneficially own 5% or more of the Company's common stock; (ii)
each of the Company's current named executive officers; (iii) each of our
directors; and (iv) all of our executive officers (as that term is defined under
the rules and regulations of the SEC) and directors as a group.

We have determined beneficial ownership in accordance with Rule 13d-3 under the
Exchange Act. Beneficial ownership generally means having sole or shared voting
or investment power with respect to securities. Unless otherwise indicated in
the footnotes to the table, each stockholder named in the table below has sole
voting and investment power with respect to the shares of common stock set forth
opposite the stockholder's name. We have based our calculation of the percentage
of beneficial ownership on 11,888,846 shares of Company's common stock
outstanding on January 9, 2023.

                                        Amount and Nature of
                                             Beneficial
     Name of Beneficial Owner(1)            Ownership(2)          Percent of Common Stock
Named Executive Officers and
Directors:
Richard A. Murphy                                  2,635,991 (3)                    20.84 %
Mark K. Patterson                                    230,000 (4)                     1.93 %
Robert S. Herlin                                      82,292                            * %
William A. Jolly                                      82,625                            * %

All current executive officers and                 3,030,908                        23.96 %
nominees as a group (4 persons)



--------------------------------------------------------------------------------

* The percentage of common stock beneficially owned is less than 1%.

(1) The address of the beneficial owners in each case is c/o Enservco

Corporation, 14133 County Road 9 ½, Longmont, CO 80504 except as indicated


      below


  (2) Calculated in accordance with Rule 13d-3 under the Exchange Act.

(3) Consists of the following: (i) 50,383 shares of common stock owned directly

by Mr. Murphy; (ii) warrants to acquire 760,805 shares of common stock held

by Cross River Partners, L.P. ("Cross River"), and (iii) 1,824,803 shares of

common stock held by Cross River. Excludes shares of common stock issuable

upon conversion of outstanding convertible notes held by Cross River whose

conversion price is not currently known or determinable. Mr. Murphy is the

managing partner of Cross River Partners, L.P. The address of Cross River

Partners, L.P. is 31 Bailey Ave, Suite D, Ridgefield, CT 06877.

(4) Consists of 230,000 shares of common stock owned by Mr. Patterson that are


      currently vested. Excludes 115,000 restricted shares that will vest on
      January 1, 2024.




--------------------------------------------------------------------------------

EQUITY COMPENSATION PLAN INFORMATION

The following is provided with respect to compensation plans (including individual compensation arrangements) under which equity securities are authorized for issuance as of December 31, 2022:



                                                                                                  Number of
                                                                                                 Securities
                                                                                                  Remaining
                                                                                                  Available
                                                                                                 for Future
                                      Number of Securities                                        Issuance
                                        to be Issued Upon            Weighted-Average           Under Equity
                                                                                                Compensation
                                           Exercise of              Exercise Price of               Plans
                                                                                                 (Excluding
                                      Outstanding Options,        

Outstanding Options, Securities


                                                                                                Reflected in
          Plan Category               Warrants, and Rights         

Warrants, and Rights Column (a))


         and Description                       (a)                         (b)                       (c)
Equity Compensation Plans Approved                                                                              (1)
by Security Holders                                        -     $                      -               484,777
Total                                                      -     $                      -               484,777


(1) The amount in this column is calculated as follows: 692,782 shares of common

stock reserved under the 2016 Plan less (i) 61,784 options that were issued

from the 2016 Plan; (ii) 96,221 shares of Restricted Stock Award shares

issued and outstanding under the 2016 Plan; and (iii) 50,000 shares issued


      from the 2016 Plan to the Company's former Chief Financial Officer as part
      of her Severance and Release Agreement.


Description of the 2016 Stock Incentive Plan



On July 18, 2016, the Board unanimously approved the adoption of the Enservco
Corporation 2016 Stock Incentive Plan (the "2016 Plan"), which was approved by
the stockholders on September 29, 2016. The 2016 Plan is administered by our
Board, which may in turn delegate authority to administer the 2016 Plan to a
committee. Our plan administrator may make grants of cash and equity awards
under the 2016 Plan to facilitate compliance with Section 162(m) of the Code.
Subject to the terms of the 2016 Plan, the plan administrator may determine the
recipients, numbers and types of awards to be granted, and the terms and
conditions of the awards, including the period of their exercisability and
vesting. On November 29, 2017, the Board established a compensation committee
that will administer the 2016 Plan.

There is no requirement to describe plans that have been approved by the Company's shareholders.



The 2016 Plan permits the granting of stock options (including both incentive
and non-qualified stock options); stock appreciation rights ("SARs"); restricted
stock and restricted stock units; performance awards of cash, stock, other
securities or property; other stock grants; and other stock-based awards.

Unless sooner discontinued or terminated by the Board, the 2016 Plan will expire
on September 29, 2026. No awards may be made after that date. However, unless
otherwise expressly provided in an applicable award agreement, any award granted
under the 2016 Plan prior to expiration extends beyond the expiration of the
2016 Plan through the award's normal expiration date.

Without the approval of the Company's stockholders, the Committee will not re-price, adjust or amend the exercise price of any options or the grant price of any SAR previously awarded, whether through amendment, cancellation and . . .

© Edgar Online, source Glimpses